# Early Treatment Strategy With High-dose Dexamethasone in Patients With SARS-CoV-2

> **NCT05293210** · PHASE3 · UNKNOWN · sponsor: **Hospital Universitario Infanta Leonor** · enrollment: 200 (estimated)

## Conditions studied

- Covid19
- Dexamethasone

## Interventions

- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT05293210
- **Lead sponsor:** Hospital Universitario Infanta Leonor
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-28
- **Primary completion:** 2023-11-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05293210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05293210, "Early Treatment Strategy With High-dose Dexamethasone in Patients With SARS-CoV-2". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05293210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*